Grip strength may predict cancer patient survival

NCT ID NCT07167082

First seen Jun 25, 2026 · Last updated Jul 02, 2026 · Updated 3 times

Summary

This completed study looked at 130 hospitalized cancer patients to see if hand grip strength could predict short-term outcomes like death within 30 days, ICU admission, or hospital readmission. Researchers measured grip strength within 24 hours of admission using a simple, non-invasive device. The goal is to find a quick, low-cost way to identify patients who may need extra support during their hospital stay.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could provide doctors with a simple, low-cost tool to identify hospitalized cancer patients at higher risk of complications or death within 30 days.
What could go wrong
This is an observational study, not a treatment trial. It only looks for associations, so it cannot prove that grip strength directly causes better or worse outcomes. Results may not apply to all cancer types or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CACHEXIA; CANCER; SARCOPENIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Etlik City Hospital, Medical Oncology Department

    Ankara, Yenimahalle, 06210, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.